CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma [Phase 3]
Summary
Phase 3 trial update on the efficacy of fevipiprant in nasal polyposis; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2021-01-05